Contractor
CYPROTEX US LLC
- UEI
- YNGLSAF57T14
- Parent UEI
- YNGLSAF57T14
- Resolved by
- uei
- Confidence
- 1.000
Active from Sep 15, 2021 to Oct 8, 2026.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 75F40126P00176 EO 14398 - PURCHASE OF DEVELOPMENT OF A HUMAN NEURAL NETWORK FORMATION NEW APPROACH METHOD FOR THE EVALUATION OF POTENTIAL DEVELOPMENTAL NEUROTOXICITY | Department of Health and Human Services | MA | Aug 10, 2026 | $70,500 |
| 75N95021P00593 TESTING OF COMPOUNDS IN CACO-2 ASSAYS | Department of Health and Human Services | MA | Sep 15, 2021 | $15,660 |
| 75N98026P00718 NCI: SERVICE: IN VITRO DRUG CANDIDATE TESTING: NON-SEVERABLE | Department of Health and Human Services | MA | Jun 9, 2026 | $77,897 |
| 75N95023P00020 FY26 UDO INITIATIVE - TESTING OF COMPOUNDS IN CACO-2 ASSAYS | Department of Health and Human Services | MA | May 22, 2026 | $51,200 |
| 75N95022P00601 FY26 UDO INITIATIVE - TESTING OF COMPOUNDS IN CYP INHIBITION, HERG INHIBITION, PPB, AND CACO-2 PERMEABILITY ASSAYS | Department of Health and Human Services | MA | May 21, 2026 | $28,052 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier YNGLSAF57T14, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Oct 21, 2026.